Community-Based Cycling Program Shows Positive Impact on Symptom Management in Parkinson Disease
High-Dose, Extended Duration Aflibercept Injections Benefit Patients With DME, nAMD
Dr Amresh Raina: Cancer Treatments Are Affecting Heart Function in Many Ways
Dampness and Mold at Home Linked With Greater Risk of Atopic Dermatitis, Asthma
Dr Neil Gross: Cemiplimab Is Producing Encouraging Results in Resectable cSCC
What We’re Reading: Swedish Scientist Wins Nobel Prize; ALS Drug Price Set; Combination Cancer, COVID-19 Deaths
In AAO Lecture, AMA CEO Discusses How the Organization Is Addressing Areas of Innovation
All 14 OneOncology Practices Apply for EOM
Futibatinib Wins Accelerated FDA Approval in Cholangiocarcinoma
Family Medicine Doctors, AI Could Be Effective in DR Screening
Most Patients in China With Lung Cancer Experience Financial Toxicity
T&E Regimen, Consistent Adherence Important to Management of nAMD
Dr Stephen Schleicher: Culture, People, Analytics Contributed to OCM Success
Which DME Drug to Try First? Patients on Bevacizumab Can Successfully Transition to Aflibercept
Review: More Research on Treatment for Extramedullary Hematopoiesis in Transfusion-Dependent Beta Thalassemia Is Needed
Oral Administration of JAK Inhibitors Shows Improved Response in Alopecia Areata
Cemiplimab Shows Improved PFS, Comparable OS to Pembrolizumab in NSCLC
Adding Pharmacists to Core Hemophilia Care Teams Improves Outcomes, Patient Costs
Four Factors Identified as Potential Risks for Comorbid CRSwNP, Asthma
Posters Emphasize Prevalence and Need for Prompt Treatment of RVO
Panel Reviews Health Inequities and Opportunities for Innovation Through Population Health Delivery
AAO Panel Offers Insight on Treatment Recommendations, In-Office Retina Surgery
Advanced Imaging System Investigated for Faster Diagnosis of Skin Cancers
Dr Melissa O'Connor Reviews Considerations for Discharge in Home Health
CAR T-Cell Therapy Outcomes Are Not Impacted by Baseline Renal Function, Study Finds
How the Name Change to Myeloproliferative Neoplasms Affected People With the Disease
What We’re Reading: FDA Approves ALS Drug; Role of Microbes in Tumors; Suicides Increased in 2021
AJMC® in the Press, September 30, 2022
Leptin Unlikely to Be Biomarker for SMA Disease Severity, Researchers Find
Contributor: It’s Time to Talk About Paying Clinical Trial Participants More